Microbio Co., Ltd. (TPEX:4128)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.60
-0.10 (-0.64%)
Apr 28, 2026, 1:30 PM CST
-32.61%
Market Cap 9.18B
Revenue (ttm) 1.89B
Net Income (ttm) -757.75M
Shares Out 588.17M
EPS (ttm) -1.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 714,699
Average Volume 1,712,807
Open 15.80
Previous Close 15.70
Day's Range 15.45 - 15.80
52-Week Range 15.15 - 30.30
Beta 0.61
RSI 33.04
Earnings Date Mar 27, 2026

About Microbio

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Mic... [Read more]

Industry Packaged Foods
Founded 2000
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4128
Full Company Profile

Financial Performance

In 2025, Microbio's revenue was 1.89 billion, an increase of 9.94% compared to the previous year's 1.72 billion. Losses were -757.75 million, -31.16% less than in 2024.

Financial Statements

News

There is no news available yet.